Chief Marketing Officer · Nautilus Biotechnology, Inc. · Common Stock
Side
BUY
Value
$5,960
Shares
4,000
Price
$1.49
Executed
Nov 6, 2025
Disclosed
Nov 10, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 10, 2025 disclosed
NAUT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Suzuki Kentaro filed this Form 4 reporting a open-market purchase of NAUT on Nov 6, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Marketing Officer
Suzuki Kentarocik:0002037191
Issuer
Nautilus Biotechnology, Inc.cik:0001808805
Revision history · 0
No field has changed since this record was first ingested.
